Par Pharmaceutical Receives Approval For Ondansetron Orally Disintegrating Tablets

Fri, 29 Dec 2006 02:00 PM EST

... Par Pharmaceutical Companies, Inc. (NYSE: PRX) today announced that it has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for ondansetron orally disintegrating tablets (ODT) in 4 mg and 8 mg strengths. [click link for full article] ...